{
      "Rank": 30,
      "Acronym": [
            "COSMOS"
      ],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "For diagnosis purpose, bone marrow sampling is performed for acute myeloid leukemia patients. 2 milliliters of this sample will be collected and analysed for the COSMOS study.",
            "Healthy donors are patients undergoing cardio-vascular surgery for their usual support. During this surgery, 2 milliliters of the bone marrow will be collected, and analysed for the COSMOS study."
      ],
      "ArmGroupInterventionName": [
            "Other: Bone marrow analyses",
            "Other: Bone marrow analyses"
      ],
      "ArmGroupLabel": [
            "Acute Myeloid Leukemia patients",
            "Healthy donors"
      ],
      "ArmGroupType": [],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT03233074"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [
            "Bone marrow"
      ],
      "BioSpecRetention": [
            "Samples With DNA"
      ],
      "BriefSummary": [
            "It is of clinical significance to better characterize the intrinsic defects harbored by mesenchymal stromal cells (MSC) in Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) context, as compared to physiological conditions. Such research initiative aims to dissect the cross-talk between malignant hematopoietic stem cells (HSC) and their bone marrow (BM) partners in crime, further prospecting for innovative stromal-directed strategies for the treatment of Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)."
      ],
      "BriefTitle": [
            "Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors"
      ],
      "CentralContactEMail": [
            "denis.guyotat@chu-st-etienne.fr",
            "Elisabeth.daguenet@chu-st-etienne.fr"
      ],
      "CentralContactName": [
            "Denis Guyotat, PhD",
            "Elisabeth Daguenet, PhD"
      ],
      "CentralContactPhone": [
            "(0)4 77 91 70 70",
            "(0)4 77 91 70 89"
      ],
      "CentralContactPhoneExt": [
            "+33",
            "+33"
      ],
      "CentralContactRole": [
            "Contact",
            "Contact"
      ],
      "CollaboratorClass": [
            "OTHER"
      ],
      "CollaboratorName": [
            "Institut de Canc\u00e9rologie de la Loire"
      ],
      "CompletionDate": [
            "September 30, 2022"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Myelodysplastic Syndromes",
            "Acute Myeloid Leukemia",
            "Cardio-vascular Surgery"
      ],
      "ConditionAncestorId": [
            "D000007938",
            "D000009370",
            "D000009369",
            "D000001855",
            "D000006402",
            "D000011230"
      ],
      "ConditionAncestorTerm": [
            "Leukemia",
            "Neoplasms by Histologic Type",
            "Neoplasms",
            "Bone Marrow Diseases",
            "Hematologic Diseases",
            "Precancerous Conditions"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC04",
            "All",
            "BC23",
            "BC15",
            "Rare"
      ],
      "ConditionBrowseBranchName": [
            "Neoplasms",
            "All Conditions",
            "Symptoms and General Pathology",
            "Blood and Lymph Conditions",
            "Rare Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Myeloid Leukemia",
            "Acute Myeloid Leukemia",
            "Myelodysplastic Syndrome",
            "Myelodysplastic Syndrome",
            "Myeloid Leukemia",
            "Acute Myeloid Leukemia",
            "Acute Myeloid Leukemia",
            "Myelodysplastic Syndrome"
      ],
      "ConditionBrowseLeafId": [
            "M10097",
            "M15507",
            "M10107",
            "M17279",
            "M13316",
            "M11297",
            "M11467",
            "M4286",
            "M8642",
            "M13263",
            "T3995",
            "T182",
            "T188",
            "T3993",
            "T170"
      ],
      "ConditionBrowseLeafName": [
            "Leukemia",
            "Syndrome",
            "Leukemia, Myeloid",
            "Leukemia, Myeloid, Acute",
            "Preleukemia",
            "Myelodysplastic Syndromes",
            "Neoplasms by Histologic Type",
            "Bone Marrow Diseases",
            "Hematologic Diseases",
            "Precancerous Conditions",
            "Myeloid Leukemia",
            "Acute Myeloid Leukemia",
            "Acute Non Lymphoblastic Leukemia",
            "Myelodysplastic Syndromes",
            "Acute Graft Versus Host Disease"
      ],
      "ConditionBrowseLeafRelevance": [
            "low",
            "low",
            "high",
            "high",
            "high",
            "high",
            "low",
            "low",
            "low",
            "low",
            "high",
            "high",
            "high",
            "high",
            "low"
      ],
      "ConditionMeshId": [
            "D000007951",
            "D000015470",
            "D000011289",
            "D000009190"
      ],
      "ConditionMeshTerm": [
            "Leukemia, Myeloid",
            "Leukemia, Myeloid, Acute",
            "Preleukemia",
            "Myelodysplastic Syndromes"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [],
      "DesignInterventionModel": [],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [
            "Case-Control"
      ],
      "DesignPrimaryPurpose": [],
      "DesignTimePerspective": [
            "Prospective"
      ],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal malignancies that are characterized by ineffective hematopoiesis, progressive bone marrow failure, cytogenetic and molecular abnormalities, and increased risk for progression to acute myeloid leukemia (AML). It is a well-accepted theory that MDS and AML originate from primary alterations of hematopoietic stem cells (HSC) compartment, which confer a survival advantage to them at the expense of physiological hematopoiesis. More recently, there is growing evidences regarding the contribution of the bone marrow (BM) microenvironment to the pathogenesis of MDS and AML. Of particular interest, several studies have pointed towards a pivotal role of mesenchymal stromal cells (MSC), one of the main components of the BM niche, in the initiation and propagation of myeloid disorders. In this context, it is of clinical significance to better characterize the intrinsic defects harbored by MSC in MDS and AML context, as compared to physiological conditions. Such research initiative aims to dissect the cross-talk between malignant HSC and their BM partners in crime, further prospecting for innovative stromal-directed strategies for the treatment of MDS and AML."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nPatients with diagnosed myelodysplasia or acute myeloid leukemia (study place: ICLN) - Specific to the cases cohort\nAge-matched healthy donors undergoing a cardiovascular surgery - Specific to the control cohort\nSigned written informed consent form\nPatient affiliated to a social security regimen or beneficiary of the same\n\nExclusion Criteria:\n\nMedical history of hematological disorders\nThrombocytopenia, anemia\u2026\nPatient under guardianship or deprived of his liberty or any condition that may affect the patient's ability to understand and sign the informed consent (art. L.1121-6, L.112-7, L.1211-8, L.1211-9)\nPregnant or breastfeeding women\nRefusing participation"
      ],
      "EnrollmentCount": [
            "150"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "Accepts Healthy Volunteers"
      ],
      "IPDSharing": [
            "No"
      ],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "Acute Myeloid Leukemia patients",
            "Healthy donors"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [
            "This is a non-interventional study for the constitution of a biobank of bone marrows, in order to further investigate in vitro the cellular properties of bone marrow-isolated mesenchymal stromal cells."
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "Bone marrow analyses"
      ],
      "InterventionOtherName": [
            "Cellular properties of mesenchymal stromal cells"
      ],
      "InterventionType": [
            "Other"
      ],
      "IsFDARegulatedDevice": [
            "No"
      ],
      "IsFDARegulatedDrug": [
            "No"
      ],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "Myelodysplastic Syndromes",
            "Acute Myeloid Leukemia",
            "Bone Marrow",
            "Mesenchymal stromal cell",
            "Healthy donor"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "February 8, 2022"
      ],
      "LastUpdatePostDateType": [
            "Actual"
      ],
      "LastUpdateSubmitDate": [
            "February 7, 2022"
      ],
      "LeadSponsorClass": [
            "OTHER"
      ],
      "LeadSponsorName": [
            "Centre Hospitalier Universitaire de Saint Etienne"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Saint-Priest-en-Jarez",
            "Saint-\u00c9tienne"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [
            "Jean-Fran\u00e7ois Fuzelier, PhD",
            "Jean-Fran\u00e7ois Fuzelier, PhD",
            "Denis Guyotat, PhD",
            "Denis Guyotat, PhD",
            "J\u00e9r\u00f4me Cornillon, PhD",
            "Fressia Honeyman, PhD",
            "Caroline Lejeune, PhD",
            "Christiane Mounier, PhD",
            "Christelle Portois, PhD",
            "Gilbert Soglu, PhD",
            "Emmanuelle Tavernier, PhD"
      ],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [
            "Contact",
            "Principal Investigator",
            "Contact",
            "Principal Investigator",
            "Sub-Investigator",
            "Sub-Investigator",
            "Sub-Investigator",
            "Sub-Investigator",
            "Sub-Investigator",
            "Sub-Investigator",
            "Sub-Investigator"
      ],
      "LocationCountry": [
            "France",
            "France"
      ],
      "LocationFacility": [
            "CHU de Saint-Etienne",
            "CHU de Saint-Etienne"
      ],
      "LocationState": [],
      "LocationStatus": [
            "Recruiting",
            "Recruiting"
      ],
      "LocationZip": [
            "42270",
            "42055"
      ],
      "MaximumAge": [
            "80 Years"
      ],
      "MinimumAge": [
            "50 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "Constitution of a Biological Cohort Following Bone Marrow Sampling From MDS or AML Patients and Age-matched Healthy Donors (COSMOS)"
      ],
      "OrgClass": [
            "OTHER"
      ],
      "OrgFullName": [
            "Centre Hospitalier Universitaire de Saint Etienne"
      ],
      "OrgStudyId": [
            "2017-0701"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "CHU de Saint-Etienne"
      ],
      "OverallOfficialName": [
            "Denis Guyotat, PhD"
      ],
      "OverallOfficialRole": [
            "Principal Investigator"
      ],
      "OverallStatus": [
            "Recruiting"
      ],
      "OversightHasDMC": [
            "No"
      ],
      "PatientRegistry": [
            "No"
      ],
      "Phase": [],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "September 30, 2022"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [
            "Changes in cellular properties of mesenchymal stromal cells isolated from bone marrow aspirates by comparing normal cells (i.e. healthy donors) and MDS/AML cells."
      ],
      "PrimaryOutcomeMeasure": [
            "Changes in cellular properties of mesenchymal stromal cells"
      ],
      "PrimaryOutcomeTimeFrame": [
            "Day 0"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [
            "Non-Probability Sample"
      ],
      "SecondaryId": [
            "2017-A02088-45"
      ],
      "SecondaryIdDomain": [
            "ANSM"
      ],
      "SecondaryIdLink": [],
      "SecondaryIdType": [
            "Other Identifier"
      ],
      "SecondaryOutcomeDescription": [
            "Number of differential biomarkers expressed by MDS or AML-derived mesenchymal stromal cells"
      ],
      "SecondaryOutcomeMeasure": [
            "Number of differential biomarkers in mesenchymal stromal cells"
      ],
      "SecondaryOutcomeTimeFrame": [
            "Day 0"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "November 17, 2017"
      ],
      "StartDateType": [
            "Actual"
      ],
      "StatusVerifiedDate": [
            "February 2022"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "July 28, 2017"
      ],
      "StudyFirstPostDateType": [
            "Actual"
      ],
      "StudyFirstSubmitDate": [
            "July 17, 2017"
      ],
      "StudyFirstSubmitQCDate": [
            "July 25, 2017"
      ],
      "StudyPopulation": [
            "Acute Myeloid Leukemia patients undergoing a bone marrow sampling for diagnosis purposes, and healthy donors undergoing cardio-vascular surgery for their usual support."
      ],
      "StudyType": [
            "Observational"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}